Status:
RECRUITING
A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Acute Myocardial Infarction (AMI)
Eligibility:
All Genders
Brief Summary
This study is a registry-based cohort investigation, prospectively enrolling patients who were diagnosed with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI)...
Detailed Description
This is a registered prospective study that consecutively enrolled patients who were diagnosed with acute myocardial infarction (AMI) and underwent primary percutaneous coronary intervention (PCI) at ...
Eligibility Criteria
Inclusion Criteria:
- Elevated or decreasing levels of cardiac troponin T, with at least one measurement exceeding 0.014 ng/mL;
- Presence of at least one of the following: symptoms of myocardial ischemia; newly onset ischemic changes on ECG; pathological Q wave; imaging evidence of new loss of viable myocardium or regional wall motion abnormalities consistent with ischemia; coronary angiography confirming the presence of a thrombus;
- Undergoing primary PCI;
- Voluntary informed consent to participate in the study.
Exclusion Criteria:
- Inability to complete emergent PCI (e.g., due to intraoperative complications or inability to tolerate the procedure).
- Prior administration of thrombolytic therapy before PCI.
- Diagnosis of type 2 or type 3 myocardial infarction.
Key Trial Info
Start Date :
February 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT07400601
Start Date
February 1 2026
End Date
December 31 2030
Last Update
February 11 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Zhongshan Hospital
Shanghai, China